Neurocrine Biosciences, Inc. (NBIX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 95.69 |
| Open | 95.50 |
| Bid | 96.81 x 900 |
| Ask | 97.59 x 800 |
| Day's range | 95.01 - 97.47 |
| 52-week range | 75.25 - 129.29 |
| Volume | |
| Avg. volume | 808,842 |
| Market cap | 9.374B |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | 62.61 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 29 Dec 1995 |
| 1y target est | N/A |
- Simply Wall St.
Neurocrine Biosciences Full Year 2022 Earnings: EPS Misses Expectations
Neurocrine Biosciences ( NASDAQ:NBIX ) Full Year 2022 Results Key Financial Results Revenue: US$1.49b (up 31% from FY...
- Simply Wall St.
Investors one-year returns in Neurocrine Biosciences (NASDAQ:NBIX) have not grown faster than the company's underlying earnings growth
It hasn't been the best quarter for Neurocrine Biosciences, Inc. ( NASDAQ:NBIX ) shareholders, since the share price...
- Zacks
Neurocrine Biosciences (NBIX) Lags Q4 Earnings Estimates
Neurocrine (NBIX) delivered earnings and revenue surprises of -23.48% and 0.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
